REYATAZ - 0003-3631-12 - (ATAZANAVIR SULFATE)

Alphabetical Index


Drug Information of REYATAZ

Product NDC: 0003-3631
Proprietary Name: REYATAZ
Non Proprietary Name: ATAZANAVIR SULFATE
Active Ingredient(s): 200    mg/1 & nbsp;   ATAZANAVIR SULFATE
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, GELATIN COATED
Coding System: National Drug Codes(NDC)

Labeler Information of REYATAZ

Product NDC: 0003-3631
Labeler Name: E.R. Squibb & Sons, L.L.C.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021567
Marketing Category: NDA
Start Marketing Date: 20030624

Package Information of REYATAZ

Package NDC: 0003-3631-12
Package Description: 60 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3631-12)

NDC Information of REYATAZ

NDC Code 0003-3631-12
Proprietary Name REYATAZ
Package Description 60 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3631-12)
Product NDC 0003-3631
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ATAZANAVIR SULFATE
Dosage Form Name CAPSULE, GELATIN COATED
Route Name ORAL
Start Marketing Date 20030624
Marketing Category Name NDA
Labeler Name E.R. Squibb & Sons, L.L.C.
Substance Name ATAZANAVIR SULFATE
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC]

Complete Information of REYATAZ


General Information